期刊
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
卷 358, 期 5, 页码 326-331出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjms.2019.08.008
关键词
Insulin pump; Continuous subcutaneous insulin infusion; Multiple dose injections; Diabetes mellitus; Hypoglycemia
资金
- Medtronic
- AMSL
- Abbott
Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII) therapy is an evolving form of insulin delivery which has been shown to be highly effective in maintaining euglycemia and providing patients with flexibility in their lives. It functions by providing the patient with a continuous subcutaneous infusion of a rapid acting insulin and allows the patient to administer boluses throughout the day for food and correction of high glucose levels. CSII is approved in patients with type 1 diabetes and selected patients with type 2 diabetes; however, it is important to select the right patients for pump therapy. Insulin pump technology continues to rapidly evolve, and many options are now on the market, including those that are used in conjunction with continuous glucose monitoring. This review article focuses on the pros and cons of CSII therapy as well as the technical and clinical considerations in starting a patient on this therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据